A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

NCT05572879 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2600
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

EuBiologics Co.,Ltd